LEXICON PHARMACEUTICALS, INC. Uncategorized Contracts & Agreements

Offer Letter (Filed With SEC on March 10, 2022)

Supplement No. 3 to the Transaction Agreements (Filed With SEC on December 18, 2020)

Open Market Sale Agreement (Filed With SEC on October 30, 2020)

First Amendment to (Filed With SEC on September 11, 2020)

Second Amendment (Filed With SEC on March 12, 2020)

Offer Letter (Filed With SEC on March 15, 2019)

Sincerely,/s/ Arthur T. Sands, M.D., Ph.D.Arthur T. Sands, M.D., Ph.D.President and Chief Executive Officer Accepted and agreed:/s/ Pablo Lapuerta, M.D.Pablo Lapuerta,... (Filed With SEC on March 8, 2012)

SUPPLEMENT NO. 2 TO TRANSACTION AGREEMENTS (Filed With SEC on February 24, 2012)

[LEXICON GENETICS LETTERHEAD] February 19, 2003 (Filed With SEC on November 8, 2010)

PURCHASEAGREEMENT SUPPLEMENT (Filed With SEC on March 19, 2010)

Exhibit No (Filed With SEC on March 16, 2010)

RESTRICTEDSTOCK UNIT AGREEMENT (Filed With SEC on February 19, 2010)

PURCHASEAGREEMENT SUPPLEMENT (Filed With SEC on October 14, 2009)

AMENDMENTTO SECURITIESPURCHASE AGREEMENT (Filed With SEC on October 7, 2009)

[LEXICONPHARMACEUTICALS LETTERHEAD] (Filed With SEC on June 2, 2009)

LEXICONPHARMACEUTICALS, INC. EQUITY INCENTIVEPLAN (Filed With SEC on April 28, 2009)

[LEXICONPHARMACEUTICALS, INC. LETTERHEAD] April29, 2008 (Filed With SEC on May 1, 2008)

Research Cost Sharing, Payment and Extension Agreement (Filed With SEC on August 8, 2007)

STOCKHOLDERS AGREEMENT (Filed With SEC on June 19, 2007)